List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Axillary Hyperhidrosis Drug Product Introduction
1.2 Global Axillary Hyperhidrosis Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Axillary Hyperhidrosis Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global Axillary Hyperhidrosis Drug Sales in Volume for the Year 2017-2028
1.3 United States Axillary Hyperhidrosis Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States Axillary Hyperhidrosis Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States Axillary Hyperhidrosis Drug Sales in Volume for the Year 2017-2028
1.4 Axillary Hyperhidrosis Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Axillary Hyperhidrosis Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Axillary Hyperhidrosis Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Axillary Hyperhidrosis Drug Market Dynamics
1.5.1 Axillary Hyperhidrosis Drug Industry Trends
1.5.2 Axillary Hyperhidrosis Drug Market Drivers
1.5.3 Axillary Hyperhidrosis Drug Market Challenges
1.5.4 Axillary Hyperhidrosis Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Axillary Hyperhidrosis Drug Market Segment by Type
2.1.1 Botulinum ToxinA
2.1.2 Glycopyrrolate
2.1.3 Glycopyrronium Tosylate
2.1.4 Others
2.2 Global Axillary Hyperhidrosis Drug Market Size by Type
2.2.1 Global Axillary Hyperhidrosis Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Axillary Hyperhidrosis Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Axillary Hyperhidrosis Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Axillary Hyperhidrosis Drug Market Size by Type
2.3.1 United States Axillary Hyperhidrosis Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Axillary Hyperhidrosis Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Axillary Hyperhidrosis Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Axillary Hyperhidrosis Drug Market Segment by Application
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Home Care
3.2 Global Axillary Hyperhidrosis Drug Market Size by Application
3.2.1 Global Axillary Hyperhidrosis Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Axillary Hyperhidrosis Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Axillary Hyperhidrosis Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Axillary Hyperhidrosis Drug Market Size by Application
3.3.1 United States Axillary Hyperhidrosis Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Axillary Hyperhidrosis Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Axillary Hyperhidrosis Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Axillary Hyperhidrosis Drug Competitor Landscape by Company
4.1 Global Axillary Hyperhidrosis Drug Market Size by Company
4.1.1 Top Global Axillary Hyperhidrosis Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global Axillary Hyperhidrosis Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global Axillary Hyperhidrosis Drug Sales by Manufacturer (2017-2022)
4.1.4 Global Axillary Hyperhidrosis Drug Price by Manufacturer (2017-2022)
4.2 Global Axillary Hyperhidrosis Drug Concentration Ratio (CR)
4.2.1 Axillary Hyperhidrosis Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Axillary Hyperhidrosis Drug in 2021
4.2.3 Global Axillary Hyperhidrosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Axillary Hyperhidrosis Drug Manufacturing Base Distribution, Product Type
4.3.1 Global Axillary Hyperhidrosis Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Axillary Hyperhidrosis Drug Product Type
4.3.3 Date of International Manufacturers Enter into Axillary Hyperhidrosis Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Axillary Hyperhidrosis Drug Market Size by Company
4.5.1 Top Axillary Hyperhidrosis Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Axillary Hyperhidrosis Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Axillary Hyperhidrosis Drug Sales by Players (2020, 2021 & 2022)
5 Global Axillary Hyperhidrosis Drug Market Size by Region
5.1 Global Axillary Hyperhidrosis Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Axillary Hyperhidrosis Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Axillary Hyperhidrosis Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Axillary Hyperhidrosis Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Axillary Hyperhidrosis Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Axillary Hyperhidrosis Drug Sales in Value by Region: 2017-2022
5.3.2 Global Axillary Hyperhidrosis Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Axillary Hyperhidrosis Drug Market Size YoY Growth 2017-2028
6.1.2 North America Axillary Hyperhidrosis Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Axillary Hyperhidrosis Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Axillary Hyperhidrosis Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Axillary Hyperhidrosis Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Axillary Hyperhidrosis Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Axillary Hyperhidrosis Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Axillary Hyperhidrosis Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Axillary Hyperhidrosis Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Axillary Hyperhidrosis Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Allergan Plc
7.1.1 Allergan Plc Corporation Information
7.1.2 Allergan Plc Description and Business Overview
7.1.3 Allergan Plc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Allergan Plc Axillary Hyperhidrosis Drug Products Offered
7.1.5 Allergan Plc Recent Development
7.2 Brickell Biotech Inc
7.2.1 Brickell Biotech Inc Corporation Information
7.2.2 Brickell Biotech Inc Description and Business Overview
7.2.3 Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Brickell Biotech Inc Axillary Hyperhidrosis Drug Products Offered
7.2.5 Brickell Biotech Inc Recent Development
7.3 Dermira Inc
7.3.1 Dermira Inc Corporation Information
7.3.2 Dermira Inc Description and Business Overview
7.3.3 Dermira Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Dermira Inc Axillary Hyperhidrosis Drug Products Offered
7.3.5 Dermira Inc Recent Development
7.4 Dr. August Wolff GmbH & Co KG Arzneimittle
7.4.1 Dr. August Wolff GmbH & Co KG Arzneimittle Corporation Information
7.4.2 Dr. August Wolff GmbH & Co KG Arzneimittle Description and Business Overview
7.4.3 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Products Offered
7.4.5 Dr. August Wolff GmbH & Co KG Arzneimittle Recent Development
7.5 GlaxoSmithKline Plc
7.5.1 GlaxoSmithKline Plc Corporation Information
7.5.2 GlaxoSmithKline Plc Description and Business Overview
7.5.3 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Products Offered
7.5.5 GlaxoSmithKline Plc Recent Development
7.6 TheraVida Inc
7.6.1 TheraVida Inc Corporation Information
7.6.2 TheraVida Inc Description and Business Overview
7.6.3 TheraVida Inc Axillary Hyperhidrosis Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 TheraVida Inc Axillary Hyperhidrosis Drug Products Offered
7.6.5 TheraVida Inc Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Axillary Hyperhidrosis Drug Industry Chain Analysis
8.2 Axillary Hyperhidrosis Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Axillary Hyperhidrosis Drug Distributors
8.3 Axillary Hyperhidrosis Drug Production Mode & Process
8.4 Axillary Hyperhidrosis Drug Sales and Marketing
8.4.1 Axillary Hyperhidrosis Drug Sales Channels
8.4.2 Axillary Hyperhidrosis Drug Distributors
8.5 Axillary Hyperhidrosis Drug Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
